Demographic and clinical characteristics | Frequency (%) |
---|---|
Sex | |
Female | 159 (40.0) |
Male | 239 (60.0) |
Age (mean = 41.5 (SD: 18.8) | |
0–24 years | 83 (20.9) |
25–34 | 102 (25.6) |
35–44 | 52 (13.1) |
45–54 | 46 (11.6) |
55 years and above | 115 (28.9) |
Residence | |
Rural | 156 (39.0) |
Urban | 242 (61.0) |
Health status on admission | |
Asymptomatic | 95 (23.9) |
Mild | 93 (23.4) |
Moderate | 80 (20.0) |
Severe | 130 (32.7) |
Comorbidity | |
Yes | 179 (45.0) |
No | 219 (55.0) |
Type of comorbidity | |
Diabetes mellitus | 68 (17.1) |
Hypertension | 41 (10.3) |
Asthma | 33 (8.3) |
Chronic pulmonary disease | 30 (7.5) |
Chronic cardiac diseases | 23 (5.8) |
Malignancy | 11 (2.8) |
Chronic kidney disease | 7 (1.8) |
HIV/AIDS | 6 (1.5) |
Types of antibiotic administered | |
Azithromycin only | 148 (37.2) |
Azithromycin + ceftriaxone | 131 (32.9) |
Azithromycin + vancomycin + ceftazidime | 50 (12.6) |
Azithromycin + ceftriaxone + metronidazole | 30 (7.5) |
Azithromycin + ceftriaxone + vancomycin | 24 (6.0) |
Azithromycin + ceftriaxone + amoxicillin | 13 (3.3) |
Azithromycin + ceftriaxone + ceftazidime | 2 (0.5) |
Dexamethasone used | |
Yes | 116 (29.1) |
No | 282 (70.9) |
Intranasal oxygen used | |
Yes | 162 (59.3) |
No | 236 (40.7) |
Length of hospital stay (mean = 14.3 SD:4.8) | |
1–7 days | 12 (3.0) |
8–14 days | 248 (61.8) |
15–21 days | 113 (28.4) |
22–28 days | 13 (3.3) |
More than 28 days | 14 (5.5) |